← Back to Search

Proton Beam Therapy

Proton Radiation for Esophageal Cancer

N/A
Recruiting
Led By Gary Yang, MD
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Endoscopy with biopsy
Age ≥ 18
Must not have
Patients with T1N0 disease and T4 disease
Medical contraindications to esophagectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is a study to see if a new cancer treatment regimen is effective, safe, and feasible.

Who is the study for?
This trial is for adults with confirmed primary squamous cell or adenocarcinoma of the esophagus, involving mid to lower regions or junction. They must have adequate organ function, no prior treatments for esophageal cancer, and be fit for surgery post-therapy. Pregnant women and those unable to use contraception are excluded.
What is being tested?
The study tests a treatment combining carboplatin/paclitaxel chemotherapy with proton radiation therapy followed by surgery. It aims to improve outcomes over traditional chemo regimens by reducing toxicity and using proton beam technology for better dose distribution in localized esophageal cancer.
What are the potential side effects?
Potential side effects include reactions related to chemotherapy such as nausea, fatigue, blood count changes, kidney function alterations; from radiation like skin irritation, difficulty swallowing; and surgical complications post-treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had an endoscopy with a tissue sample taken.
Select...
I am 18 years old or older.
Select...
My cancer is in an early to mid-stage according to AJCC guidelines.
Select...
My cancer is a specific type found in the middle, lower esophagus, or where it meets the stomach.
Select...
I have had a bronchoscopy to check for fistula in my upper lung area.
Select...
My recent blood test shows my bone marrow is working well.
Select...
My cancer has spread to nearby lymph nodes but any enlargement is 2cm or less.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer is either very small and not spread to lymph nodes or very large.
Select...
I cannot undergo surgery to remove my esophagus due to health reasons.
Select...
My cancer has spread to my windpipe or major airways.
Select...
I am not pregnant, nursing, or able to become pregnant and use effective birth control.
Select...
I have cancer in the upper part of my esophagus.
Select...
I have had radiation therapy for esophageal cancer or in the chest area before.
Select...
I have had chemotherapy for esophageal cancer before.
Select...
I haven't had cancer (other than non-melanoma skin cancer) in the last 2 years.
Select...
I have had radiotherapy where the treated areas overlapped.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Proton radiationExperimental Treatment1 Intervention
Proton radiation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Proton radiation
2011
Completed Phase 2
~20

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
316 Previous Clinical Trials
266,637 Total Patients Enrolled
Gary Yang, MDPrincipal Investigator - gyang@llu.edu
Loma Linda University
3 Previous Clinical Trials
51 Total Patients Enrolled

Media Library

Proton Radiation (Proton Beam Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT01684904 — N/A
Esophageal Cancer Research Study Groups: Proton radiation
Esophageal Cancer Clinical Trial 2023: Proton Radiation Highlights & Side Effects. Trial Name: NCT01684904 — N/A
Proton Radiation (Proton Beam Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01684904 — N/A
~7 spots leftby Aug 2027